Skip to content
Menu
Qualify for a Medical Study for Rheumatoid Arthritis
Treatment
About
FAQ
See If You Qualify
Close Menu
Biologic and targeted synthetic DMARDs include:
Abatacept (Orencia)
Adalimumab (Humira)
Anakinra (Kineret)
Baricitinib (Olumiant)
Certolizumab (Cimzia)
Etanercept (Enbrel)
Golimumab (Simponi)
Infliximab (Remicade)
Rituximab (Rituxan, MabThera)
Sarilumab (Kevzara)
Tocilizumab (Actemra)
Tofacitiniib (Xeljanz, Xeljanz XR)
Upadacitinib (Rinvoq)
Conventional synthetic DMARDs include:
Hydroxychloroquine (Plaquenil)
Leflunomide (Arava)
Methotrexate (Rheumatrex, Trexall, Otrexup, Rasuvo)
Sulfasalazine (Azulfidine)
